Abstract
The authors report on three chronic, treatment refractory schizophrenic patients who dramatically improved when placed on very high doses of loxapine (300-500 mg/day). Numbness transiently appeared in two patients at very high doses of loxapine; it may be a frequently occurring but unreported side effect. The relative lack of serious side effects to very high dose loxapine suggests that this may be a useful intervention in carefully selected refractory patients. The authors recommended that controlled studies be done to elucidate the benefit to risk ratio.
Original language | English (US) |
---|---|
Pages (from-to) | 1212-1214 |
Number of pages | 3 |
Journal | American Journal of Psychiatry |
Volume | 138 |
Issue number | 9 |
DOIs | |
State | Published - Jan 1 1981 |
ASJC Scopus subject areas
- Psychiatry and Mental health